REGULATED PRESS RELEASE published on 07/01/2024 at 07:00, 1 year 7 months ago Biophy(s a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris Biophytis présente les résultats de l'étude COVA de phase 2-3 sur les formes sévères de Covid-19 lors du WCID à Paris. Des résultats positifs de réduction du risque de défaillance respiratoire et de mortalité sont révélés Biophytis COVID-19 Résultats Positifs Étude COVA Réduction Du Risque De Mortalité
REGULATED PRESS RELEASE published on 07/01/2024 at 07:00, 1 year 7 months ago Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris Biophytis presented positive results of its Phase 2-3 COVA study for severe Covid-19 at WCID in Paris, showing reduction in respiratory failure and death rates Biophytis COVID-19 Positive Results Phase 2-3 COVA Study
BRIEF published on 06/25/2024 at 23:05, 1 year 7 months ago Biophytis Approves All Resolutions at General Meeting Shareholders Biophytis General Meeting Resolutions
BRIEF published on 06/25/2024 at 23:05, 1 year 7 months ago Résultats de l'Assemblée Générale Mixte de Biophytis du 24 juin 2024 Biophytis Assemblée Générale Resolutions Quorum Vote
REGULATED PRESS RELEASE published on 06/25/2024 at 23:00, 1 year 7 months ago RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024 Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation Shareholders General Meeting Resolutions Approval Biophytis SA
REGULATED PRESS RELEASE published on 06/25/2024 at 23:00, 1 year 7 months ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024 Biophytis annonce l'approbation des résolutions lors de l'Assemblée Générale Mixte du 24 Juin 2024. Détails des décisions et perspectives de la société Biophytis Biotechnologie Assemblée Générale Mixte Approbation Des Résolutions Développement De Traitements
BRIEF published on 06/20/2024 at 07:05, 1 year 7 months ago Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine Biophytis Partenariat Amérique Latine BIO101 Blanver
BRIEF published on 06/20/2024 at 07:05, 1 year 7 months ago Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million Biophytis Pharmaceuticals Latin America BIO101 Blanver
PRESS RELEASE published on 06/20/2024 at 07:00, 1 year 7 months ago Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
PRESS RELEASE published on 06/20/2024 at 07:00, 1 year 7 months ago Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€ Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€. Accord de licence exclusive pour la commercialisation de BIO101, y compris dans l’obésité et les infections respiratoires Biophytis Accord BIO101 Blanver Am\u00e9rique Latine
Published on 01/31/2026 at 03:15, 1 day 10 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 11 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 14 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 21 hours 40 minutes ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 1 hour ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 10 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 15 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 17 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 18:40, 1 day 18 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 1 day 19 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 19 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 5 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés